Similar Search Results

A new retrospective on mergers

Scherer, Frederic M. - In: The economics of corporate governance and mergers, (pp. 187-202). 2008

Persistent link: https://www.econbiz.de/10003757891

Financial mergers and their consequences

Scherer, Frederic M. - 2012

Persistent link: https://www.econbiz.de/10009572886

Mergers and innovation in the pharmaceutical market

Comanor, William S.; Scherer, Frederic M. - 2011

Persistent link: https://www.econbiz.de/10009487486

Financial mergers and their consequences

Scherer, Frederic M. - 2013

Persistent link: https://www.econbiz.de/10009752022

Merger efficiencies and competition policy

Scherer, Frederic M. - 2012

Persistent link: https://www.econbiz.de/10009663270

Mergers and innovation in the pharmaceutical industry

Comanor, William S.; Scherer, Frederic M. - In: Journal of health economics 32 (2013) 1, pp. 106-113

Persistent link: https://www.econbiz.de/10009703553

Corporate takeovers : the efficiency arguments

Scherer, Frederic M. - In: Competition policy, domestic and international, (pp. 239-252). 2000

Persistent link: https://www.econbiz.de/10003047235

[Rezension von: Lichtenberg, F. R., Corporate takeovers and productivity]

Scherer, Frederic M. - In: Journal of economics 58 (1993) 2, pp. 216-218

Persistent link: https://www.econbiz.de/10001346142

[Rezension von: Kumar, M.S., Growth, acquisition and investment]

Scherer, Frederic M. - In: Journal of economics 46 (1986) 1, pp. 78-80

Persistent link: https://www.econbiz.de/10001342545

Mergers and Innovation in the Pharmaceutical Industry

Comanor, William S. - 2012

Conflicting trends confound the pharmaceutical industry. The productivity of pharmaceutical innovation has declined in recent years. At the same time, the cohort of large companies who are the leading engines of pharmaceutical R&D has become increasingly concentrated. The concurrent presence of...

Persistent link: https://www.econbiz.de/10013096412